NCT04706702

Brief Summary

Knee osteoarthritis (OA) is highly prevalent and a leading cause of pain that limits physical functioning in older adults. Clinical practice guidelines recommend physical exercise for managing symptoms of knee OA. As a result, several evidence-based exercise programs have been implemented in community centers. However, access to these programs is severely limited in rural settings. Considering that rural communities have a higher disease burden and higher proportion of older adults than non-rural areas, there is a critical need to (1) adapt evidence-based exercise programs for remote delivery to increase access for rural older adults and (2) develop pathways to implement exercise programs in rural health care systems that consistently reach and engage patients with knee OA. Accordingly, we aim to engage rural primary care practices (including medical directors, clinicians, and staff) to develop a clinical pathway that refers patients to an evidence-based exercise program, called Enhance Fitness® (EF), which we have adapted for remote delivery (tele-EF). Enhance Fitness is a group exercise program that is recommended by the CDC for OA management. It is available in over 800 sites nationally and is covered by Medicare Advantage plans, but it is generally not available in rural communities. In addition, we will assess the feasibility and acceptability of implementing the clinical pathway that identifies physically inactive older patients with knee OA, facilitates exercise prescription, and streamlines referral to tele-EF in a rural primary care clinic over a 5-month period.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 8, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 13, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2022

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
Last Updated

January 13, 2021

Status Verified

January 1, 2021

Enrollment Period

12 months

First QC Date

January 8, 2021

Last Update Submit

January 10, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Active minutes per day

    Average number of minutes spent in moderate to vigorous physical activity as measured by the activPAL accelerometer

    Change from Baseline Active Minutes at 12 weeks

Secondary Outcomes (2)

  • Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function 8-item Short Form

    Change from Baseline PROMIS Physical Function score at 12 weeks

  • Knee injury and Osteoarthritis Outcome Score (KOOS) Physical Function Subscale

    Change from Baseline KOOS Physical Function Subscale score at 12 weeks

Study Arms (1)

Tele-EF

EXPERIMENTAL

Tele-EnhanceFitness

Behavioral: Tele-EnhanceFitness

Interventions

Livestream, instructor-led tele-exercise classes, involving balance, endurance, and strength training

Tele-EF

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥65 years
  • Community-dwelling
  • English-speaking
  • Physician diagnosed knee osteoarthritis
  • Physically inactive as determined by the 2-item Physical Activity Vital Sign questionnaire

You may not qualify if:

  • Cognitive impairment determined by a Mini Montreal Cognitive Assessment score of \<11
  • Significant, non-corrected visual or hearing impairment
  • Plans to move out of the area in the next 6 months
  • Cancer requiring treatment (except for non-melanoma skin cancer) in the past 6 months
  • Heart attack in the past 6 months
  • Stroke in the past 6 months
  • Hip fracture in the past 6 months
  • Hip/knee replacement in the past 6 months
  • Spinal surgery in the past 6 months
  • Heart surgery in the past 6 months
  • Deep vein thrombosis in the past 6 months
  • Pulmonary embolus in the past 6 months
  • Hospitalization within the last month
  • ≥3 falls within the past month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington

Seattle, Washington, 98195-6540, United States

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Kushang V Patel, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kushang V Patel, PhD

CONTACT

Elise V Hoffman, BS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Associate Professor

Study Record Dates

First Submitted

January 8, 2021

First Posted

January 13, 2021

Study Start

March 1, 2021

Primary Completion

February 18, 2022

Study Completion

February 28, 2022

Last Updated

January 13, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will share

The investigators recognize that data sharing leads to the promotion of science. We intend to publish the results of the proposed study and will make data available to investigators upon request (following publication). The final dataset will include demographic, clinical, and behavioral data on 15 older adults followed over a 3-month period. Even though the final dataset will be stripped of identifiers prior to release for sharing, we believe that the possibility of deductive disclosure of subjects with unusual characteristics remains. For these reasons, we propose to make the data and associated documentation available to users under a data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed.

Locations